Boston Scientific (NY:BSX)

42.60 -0.63 (-1.46%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9

...

30 31 Next >

Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape

February 19, 2026

On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire...

Via MarketMinute

Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector

February 19, 2026

Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for its fiscal third quarter of 2026, marking a significant turning point for the medical technology giant. The...

Via MarketMinute

Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum

February 17, 2026

Today’s Date: February 17, 2026 Introduction Medtronic plc (NYSE: MDT) has long been the sleeping giant of the medical technology sector. For years, the Dublin-domiciled powerhouse was viewed by Wall...

Via Finterra

Topics Artificial Intelligence Earnings Economy

3 S&P 500 Stocks Worth Investigating

February 15, 2026

The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for...

Via StockStory

Topics Stocks

Boston Scientific Corp (NYSE:BSX) Emerges as a Prime GARP Candidate ↗

February 13, 2026

Via Chartmill

The Top 5 Analyst Questions From Boston Scientific’s Q4 Earnings Call

February 11, 2026

Boston Scientific’s fourth quarter results were met with a significant negative market reaction, despite meeting revenue expectations and delivering adjusted earnings above analyst consensus....

Via StockStory

Topics Earnings

Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

February 09, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

SNAP, BSX, PYPL Stocks Hit 52-Week Lows — But Refuse To Stay Down After-Hours ↗

February 04, 2026

Via Stocktwits

Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination

February 09, 2026

Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5...

Via Finterra

Topics Artificial Intelligence Economy Product Recall

3 Safe-and-Steady Stocks to Consider Right Now

February 08, 2026

Stocks with low volatility can be a great foundation for a portfolio, especially for investors looking to reduce risk. While they don’t often make headlines, these companies provide consistency in an...

Via StockStory

Boston Scientific Corporation (BSX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

February 06, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

February 06, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

The $3.2 Trillion ‘Wall of Capital’: Private Equity Unleashes a Global M&A Renaissance in 2026

February 06, 2026

As of February 6, 2026, the global financial landscape is being reshaped by an unprecedented "wall of capital." After nearly two years of stagnation caused by valuation gaps and high borrowing costs,...

Via MarketMinute

Topics Artificial Intelligence Economy Energy

The Great Rebound: US M&A Activity Surges 111% as Megadeals Return to Wall Street

February 06, 2026

The long-awaited "deal drought" has officially broken. As of early February 2026, the American financial landscape is being reshaped by a massive resurgence in corporate deal-making, punctuated by a...

Via MarketMinute

Topics Artificial Intelligence Economy Government

The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition

February 05, 2026

In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for...

Via MarketMinute

Topics Supply Chain

Biotech Healthcare: CSDX, NWBO, BSEM, RDGL, NRXBF Emerging Stocks to Watch

February 05, 2026

Via AB Newswire

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗

February 05, 2026

Via Chartmill

The Return of the Giants: Private Equity Mega-Deals Surge in Early 2026

February 05, 2026

The "Great Hesitation" in global finance has officially come to an end. In the opening weeks of 2026, the private equity landscape has undergone a dramatic transformation, shifting from two years of...

Via MarketMinute

Topics Artificial Intelligence Economy Initial Public Offering

Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)

February 05, 2026

February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left...

Via Finterra

Topics Product Recall World Trade

BSX Q4 Deep Dive: Growth Engines Face Scrutiny as Market Reacts to Guidance and Segment Dynamics

February 05, 2026

Medical device company Boston Scientific (NYSE:BSX) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 15.9% year on year to $5.29 billion. The company expects next quarter’s revenue to...

Via StockStory

Topics Economy World Trade

Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors ↗

February 04, 2026

Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.

Via The Motley Fool

Topics Earnings Stocks

Explore the top gainers and losers within the S&P500 index in today's session. ↗

February 04, 2026

Via Chartmill

These S&P500 stocks are the most active in today's session ↗

February 04, 2026

Via Chartmill

Why Boston Scientific Stock Plummeted Today ↗

February 04, 2026

I'll be keeping a close eye on Boston Scientific stock following the market's peculiar reaction to its solid earnings report.

Via The Motley Fool

Boston Scientific (BSX) Earnings Transcript ↗

February 04, 2026

Boston Scientific (BSX) Earnings Transcript

Via The Motley Fool

Wednesday's session: top gainers and losers in the S&P500 index ↗

February 04, 2026

Via Chartmill

Why Boston Scientific (BSX) Shares Are Getting Obliterated Today

February 04, 2026

Shares of medical device company Boston Scientific (NYSE:BSX) fell 13.9% in the afternoon session after the company reported fourth-quarter 2025 results that beat Wall Street estimates but provided a...

Via StockStory

Gapping S&P500 stocks in Wednesday's session ↗

February 04, 2026

Via Chartmill

Boston Scientific Stock Hits 52-Week Low On Soft 2026 Outlook ↗

February 04, 2026

Boston Scientific Corporation (NYSE: BSX) reported Q4 2025 revenues of $5.29B, beating management guidance and consensus estimate.

Via Benzinga

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

February 04, 2026

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.